Back to Rankings

PGEN

PrecigenB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PGEN vs peer average
61/100
PGEN vs. peer average (B vs. C)
Grade spread
A 1 · B 4 · C 2 · D 1 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

BHVN is the first available peer comparator.

Better commercialization-stage biotech comparator than most packet peers because investor focus also sits on pipeline optionality versus execution, though disease focus differs.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerBHVNBiohaven
PGEN
Precigen
BHVN
Biohaven
Grade
B
F
Momentum
68
26
Value
41
41
Sentiment
69
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs BHVN

PGEN / BHVN
Grade Position
In line
PGEN vs. peer average (B vs. C)
61/100
Momentum
68
PGEN
Value
41
PGEN
Sentiment
69
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PGEN
1
BHVN
BHVN
F
20/100
+3
2
ABCL
ABCL
B
80/100
Even
3
ATAI
ATAI
B
80/100
Even
4
INBX
Inhibrx Biosciences Inc Common
D
40/100
+2
5
ARDX
Ardelyx Inc Common
C
60/100
+1
BHVN is the first peer returned for this comparison set.